AKAM vs IVF · P/E 27, rev $2.17B vs rev $2.2M
Akamai Technologies Inc (AKAM) versus INVO Fertility, Inc. (IVF) — a side-by-side from cached financials, not a winner call.
Akamai Technologies Inc (AKAM) is a software - infrastructure company listed on US.
INVO Fertility, Inc. (IVF) is a medical devices company listed on US.
Latest reported AKAM revenue for 2026-06-30 was $2.17B. Net income was $185.7M. AKAM currently screens at market cap $11.31B and trailing P/E 26.7.
Latest reported IVF revenue for 2026-06-30 was $2.2M. Net income was $888.7K. Revenue was up 8.0% from 2026-03-31 to 2026-06-30. IVF currently screens at market cap $2.8M.
AKAM currently screens at market cap $11.31B and trailing P/E 26.7. IVF currently screens at market cap $2.8M.
Not investment advice. Open the AKAM and IVF stock pages for the full models.
Not investment advice.